Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01932216 · ClinicalTrials.gov registry record · NA

Cosmesis, Patient Satisfaction and Quality of Life After da Vinci Single Site and Multiport Laparoscopic Cholecystectomy

A NA study, sponsored by Intuitive Surgical.

Completed
Registry status
NA
Development phase
136
Enrollment target

NCT01932216: Completed NA study, sponsored by Intuitive Surgical.

NCT01932216 is a NA study that has completed, run by Intuitive Surgical. The registered enrollment target is 136 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01932216, a NA study, has completed, sponsored by Intuitive Surgical.

COMPLETED
Registry status
NA
Development phase
136 participants
Enrollment target

Study Summary

Prospective, randomized , multicenter study comparing cholecystectomy performed with da Vinci Single Site Instruments™ to multi-port (four ports) laparoscopy

Primary Outcome

The primary objective of this study is to evaluate cosmesis, patient satisfaction and quality of life after robotic- assisted single incision cholecystectomy procedure using da Vinci Single- Site Instruments™ in comparison to a multiport laparoscopic approach.

Interventions

  • PROCEDURE Cholecystectomy

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2013-09
Est. Completion 2017-03
Phase NA
Intuitive Surgical

40 total trials

What the finished NCT01932216 record still lists

NCT01932216 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 1 intervention - of which Cholecystectomy is the first listed.

NCT01932216 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01932216 about?

NCT01932216 is a clinical study titled "Cosmesis, Patient Satisfaction and Quality of Life After da Vinci Single Site and Multiport Laparoscopic Cholecystectomy". Prospective, randomized , multicenter study comparing cholecystectomy performed with da Vinci Single Site Instruments™ to multi-port (four ports) laparoscopy

What is the current status of trial NCT01932216?

This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2013-09. Estimated completion is 2017-03.

What interventions are being tested in trial NCT01932216?

The interventions under investigation include: Cholecystectomy (PROCEDURE).

Who is sponsoring clinical trial NCT01932216?

This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01932216's enrollment target sits among peer trials

136 722nd of 2000 higher than 1,275 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01555892 · 136 participants · Phase 1

    Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

  • NCT03216525 · 136 participants · Phase 3

    Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

  • NCT04476901 · 136 participants · Phase 2

    Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

  • NCT04603898 · 136 participants · NA

    Oxalate Formation From Ascorbic Acid

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01932216, the US trial registry maintained by the National Library of Medicine. NCT01932216 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.